Lantern Pharma, Inc. a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, expanded its clinical development team with the addition of Reggie Ewesuedo as vice president of clinical development, and several additional team members. The expansion of the clinical development team will continue to advance the Harmonic Trial, a Phase ...